Outcome of Rituximab-Based Treatment for Post-Transplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience

BACKGROUND: Post-transplant lymphoproliferative disorder (PTLD) is a rare complication following solid organ transplantation and allogeneic hematopoietic stem cell transplantation (Allo-HSCT), which gives rise to high mortality rates. MATERIAL/METHODS: This was a single-center retrospective analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Cheng-ying, Zhao, Sha-sha, Wang, Xiao-kai, Wang, Li, Wang, Fei-yan, Fang, Shu, Liu, Zhan-xiang, Guan, Li-xun, Liu, Yu-chen, Ding, Yi, Dou, Li-ping, Wang, Li-li, Gao, Chun-ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463616/
https://www.ncbi.nlm.nih.gov/pubmed/30940797
http://dx.doi.org/10.12659/AOT.914101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463616/
https://www.ncbi.nlm.nih.gov/pubmed/30940797
http://dx.doi.org/10.12659/AOT.914101

Ejemplares similares